Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT02844257
Eligibility Criteria:
Inclusion Criteria:
* Patient \> 15 years old
* Newly diagnosed AML or post myelodysplastic syndrome (MDS)
Exclusion Criteria:
* Patients with M3 AML of French-American-British (FAB) classification (APL, Acute Promyelocytic Leukemia)
* World Health Organization (WHO) performance status \>2; (ii)
* Left ventricular systolic ejection fraction below the normal range
* Patients who have any severe and/or uncontrolled medical conditions or other conditions that could affect their participation in the study
* Serum creatinine concentration \> 2x ULN (Upper Limit of Normal laboratory ranges),
* AST or ALT levels \> 2.0 x upper limit of normal (ULN), except if AML-related
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
83 Years
Study:
NCT02844257
Study Brief:
Protocol Section:
NCT02844257